Fusion protein engineered exosomes for targeted degradation of specific RNAs in lysosomes: a proof-of-concept study.

Fusion protein engineered exosomes for targeted degradation of specific RNAs in lysosomes: a proof-of-concept study.
复制标题

融合蛋白工程外泌体用于溶酶体中特定 RNA 的靶向降解:一项概念验证研究

DOI:
10.1080/20013078.2020.1816710
复制
发表时间:
2020-09-06
影响因子:
16
通讯作者:
Yuan L
Yuan L
中科院分区:
医学2区
文献类型:
--
作者:
Li Z;Zhou X;Gao X;Bai D;Dong Y;Sun W;Zhao L;Wei M;Yang X;Yang G;Yuan L

文献摘要

参考文献

被引文献

相似文献

摘要 治疗性干预体内 RNA 的功能仍然是一个巨大的挑战。我们在这里开发了一种基于外泌体的策略来传递工程化的RNA结合蛋白,以便将特定的RNA招募到溶酶体进行降解。作为一项原理验证研究,RNA 结合蛋白 HuR 融合到 Lamp2b(一种位于外泌体和溶酶体中的膜蛋白)的 C 末端。融合蛋白能够掺入外泌体中。此外,用 Lamp2b-HuR 改造的外泌体可能通过溶酶体介导的降解成功地降低了 RNA 靶标的丰度,特别是当外泌体被酸化时。该系统对巨噬细胞特别有效,巨噬细胞富含溶酶体并且对常规转染介导的 RNAi 策略具有抵抗力。在 CCl4 诱导的肝损伤小鼠模型中,我们发现用 Lamp2b-HuR 工程化的酸化外泌体的递送显着减少了肝纤维化,同时减少了 miR-155 和其他炎症基因。综上所述,所建立的基于外泌体的RNA结合蛋白递送策略,即“外泌体介导的溶酶体清除”,利用了外泌体在靶向递送方面的优势,在体内调控一组基因方面具有广阔的前景。
ABSTRACT Therapeutically intervening the function of RNA in vivo remains a big challenge. We here developed an exosome-based strategy to deliver engineered RNA-binding protein for the purpose of recruiting specific RNA to the lysosomes for degradation. As a proof-of-principle study, RNA-binding protein HuR was fused to the C-terminus of Lamp2b, a membrane protein localized in both exosome and lysosome. The fusion protein was able to be incorporated into the exosomes. Moreover, exosomes engineered with Lamp2b-HuR successfully decreased the abundance of RNA targets possibly via lysosome-mediated degradation, especially when the exosomes were acidified. The system was specifically effective in macrophages, which are lysosome enriched and resistant to routine transfection mediated RNAi strategy. In the CCl4-induced liver injury mouse model, we found that delivery of acidified exosomes engineered with Lamp2b-HuR significantly reduced liver fibrosis, together with decreased miR-155 and other inflammatory genes. In summary, the established exosome-based RNA-binding protein delivery strategy, namely “exosome-mediated lysosomal clearance”, takes the advantage of exosome in targeted delivery and holds great promise in regulating a set of genes in vivo.
DOI: 10.1038/nbt.1807
发表时间: 2011-04-01
影响因子: 46.9
作者:
Alvarez-Erviti, Lydia;Seow, Yiqi;Wood, Matthew J. A.
通讯作者: Wood, Matthew J. A.
DOI: 10.1016/j.molmed.2017.05.003
发表时间: 2017-07
影响因子: 13.6
作者:
Conlan RS;Pisano S;Oliveira MI;Ferrari M;Mendes Pinto I
通讯作者: Mendes Pinto I
DOI: 10.1016/j.jhep.2016.01.035
发表时间: 2016-06
影响因子: 25.7
作者:
Bala S;Csak T;Saha B;Zatsiorsky J;Kodys K;Catalano D;Satishchandran A;Szabo G
通讯作者: Szabo G
DOI: 10.1016/j.jconrel.2013.08.014
发表时间: 2013-11-28
影响因子: 10.8
作者:
Kooijmans, Sander A. A.;Stremersch, Stephan;Vader, Pieter
通讯作者: Vader, Pieter
DOI: 10.1021/nn402753y
发表时间: 2013-08-27
期刊: ACS NANO
影响因子: 17.1
作者:
Tang, Rui;Kim, Chang Soo;Solfiell, David J.;Rana, Subinoy;Mout, Rubul;Velazquez-Delgado, Elih M.;Chompoosor, Apiwat;Jeong, Youngdo;Yan, Bo;Zhu, Zheng-Jiang;Kim, Chaekyu;Hardy, Jeanne A.;Rotello, Vincent M.
通讯作者: Rotello, Vincent M.